Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mov Disord ; 15(3): 542-51, 2000 May.
Article in English | MEDLINE | ID: mdl-10830422

ABSTRACT

Systemic administration of the L-type calcium channel agonists +/-Bay K 8644 or FPL 64176 causes a characteristic pattern of motor dysfunction in normal C57BL/6J mice that resembles generalized dystonia. There is no associated change in the electroencephalogram, confirming that the motor disorder does not reflect epileptic seizures. However, the electromyogram reveals an increase in baseline motor unit activity with prolonged phasic discharges consistent with dystonia. The duration and severity of dystonia is dependent on the dose administered and the age of the animal at testing. The effects are transient, with the return of normal motor behavior 1-4 hours after treatment. Similar effects can be provoked by intracerebral administration of small amounts of the drugs, indicating a centrally mediated response. Dystonia can be attenuated by co-administration of dihydropyridine L-type calcium channel antagonists (nifedipine, nimodipine, and nitrendipine) but not by non-dihydropyridine antagonists (diltiazem, verapamil, and flunarizine). These results implicate abnormal function of L-type calcium channels in the expression of dystonia in this model.


Subject(s)
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Calcium Channel Agonists/pharmacology , Calcium Channels/physiology , Dystonia/physiopathology , Pyrroles/pharmacology , Animals , Brain Mapping , Dose-Response Relationship, Drug , Electroencephalography/drug effects , Electromyography/drug effects , Locomotion/drug effects , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Neurologic Examination/drug effects
2.
Proc Natl Acad Sci U S A ; 96(26): 15228-32, 1999 Dec 21.
Article in English | MEDLINE | ID: mdl-10611367

ABSTRACT

The L type calcium channel agonist (+/-)Bay K 8644 has been reported to cause characteristic motor abnormalities in adult mice. The current study shows that administration of this drug can also cause the unusual phenomenon of self-injurious biting, particularly when given to young mice. Self-biting is provoked by injecting small quantities of (+/-)Bay K 8644 directly into the lateral ventricle of the brain, suggesting a central effect of the drug. Similar behaviors can be provoked by administration of another L type calcium channel agonist, FPL 64176. The self-biting provoked by (+/-)Bay K 8644 can be inhibited by pretreating the mice with dihydropyridine L type calcium channel antagonists such as nifedipine, nimodipine, or nitrendipine. However, self-biting is not inhibited by nondihydropyridine antagonists including diltiazem, flunarizine, or verapamil. The known actions of (+/-)Bay K 8644 as an L type calcium channel agonist, the reproduction of similar behavior with another L type calcium channel agonist, and the protection afforded by certain L type calcium channel antagonists implicate calcium channels in the mediation of the self-biting behavior. This phenomenon provides a model for studying the neurobiology of this unusual behavior.


Subject(s)
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/adverse effects , Behavior, Animal/physiology , Bites and Stings , Calcium Channels, L-Type/metabolism , Self-Injurious Behavior/chemically induced , Aggression/physiology , Animals , Calcium Channel Agonists/adverse effects , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Dihydropyridines/chemistry , Diltiazem/pharmacology , Ion Channel Gating , Mice , Mice, Inbred C57BL , Nifedipine/pharmacology , Nimodipine/pharmacology , Nitrendipine/pharmacology , Pyrroles/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...